Palladyne AI Corp.
PDYN Nasdaq Services-Prepackaged Software Financials FY2020βFY2025
What Palladyne AI Corp. does
No business description yet.
- Legal name
- Palladyne AI Corp.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 5, 2026
- Accession Β· CIK
- 0001193125-26-092443
0001826681
Revenue and margins
Palladyne AI Corp. had $5.2M of revenue in fiscal 2025, down 32.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β$28.4M in fiscal 2025, β540.4% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Palladyne AI Corp. returned β to shareholders in fiscal 2025. The diluted share count rose 57.3%.
Balance sheet
Cash, debt and the ratios that show how comfortably Palladyne AI Corp. can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $217M | $114M | $39.1M | $40.1M | $47.1M |
| Current ratio | 37.1x | 12.3x | 5.3x | 9.6x | 9.3x |
| Quick ratio | 36.9x | 11.9x | 5.2x | 9.6x | 9.2x |
| Total assets | $236M | $168M | $60.4M | $56.3M | $95.7M |
| Total liabilities | $21.9M | $23.2M | $19.5M | $65.8M | $21.0M |
| Shareholders' equity | $214M | $144M | $40.9M | β$9.5M | $74.7M |
| Net debt (β = net cash) | β | β | β | β | β |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Net income is positive | β | β | β | β | β | β |
| Cash from operations is positive | β | β | β | β | β | β |
| Return on assets rose | β | β | β | β | β | β |
| Cash from operations exceeds net income | β | β | β | β | β | β |
| Debt fell relative to assets | β | β | β | β | β | β |
| Current ratio rose | β | β | β | β | β | β |
| Share count didn't rise | β | β | β | β | β | β |
| Gross margin rose | β | β | β | β | β | β |
| Revenue rose relative to assets | β | β | β | β | β | β |
| F-score | β / 3 | 3 / 8 | 3 / 8 | 2 / 8 | 5 / 8 | 2 / 8 |
| Accruals ratio | β10.6% | β28.8% | β45.5% | β34.2% | β85.7% | 49.6% |
| Altman Z'' | 3.17 | 12.14 | β1.80 | β29.84 | β27.35 | β11.71 |
6 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | $8.8M | $5.1M | $14.6M | $6.1M | $7.8M | $5.2M |
| Net interest income | $0.0M | β$0.0M | $1.8M | $3.3M | $1.2M | $1.9M |
| Gross profit | $3.2M | $1.2M | $3.0M | $1.1M | $4.3M | $2.6M |
| Research and development | $14.1M | $17.5M | $34.1M | $39.0M | $10.4M | $12.9M |
| Operating income | β$21.0M | β$81.0M | β$177M | β$121M | β$26.9M | β$32.4M |
| Pretax income | β$20.9M | β$81.5M | β$161M | β$116M | β$72.6M | $7.5M |
| Income tax | $0.0M | $0.0M | β$3.9M | $0.0M | $0.0M | β$2.5M |
| Net income | β$20.9M | β$81.5M | β$157M | β$116M | β$72.6M | $10.0M |
| Net income to common | β$20.9M | β$81.5M | β$157M | β$116M | β$72.6M | $10.0M |
| Diluted EPS | β$0.21 | β$0.72 | β$6.42 | β$4.51 | β$2.71 | $0.24 |
| Diluted shares | 0.10B | 0.11B | 0.02B | 0.03B | 0.03B | 0.04B |
| Cash flow | ||||||
| Cash from operations | β$16.9M | β$42.1M | β$65.4M | β$76.6M | β$22.6M | β$27.6M |
| Capital expenditure | $1.0M | $4.7M | $1.5M | $0.8M | $0.3M | $0.7M |
| Free cash flow | β$17.8M | β$46.8M | β$66.9M | β$77.4M | β$22.9M | β$28.4M |
| Depreciation and amortization | $0.5M | $0.5M | $1.4M | $1.6M | $0.8M | $1.0M |
| Stock-based compensation | $2.3M | $43.1M | $35.6M | $12.0M | $2.8M | $4.4M |
| Acquisitions | β | β | $29.7M | β | $0.0M | $5.3M |
| Balance sheet | ||||||
| Cash and short-term investments | $33.7M | $217M | $114M | $39.1M | $40.1M | $47.1M |
| Finance lease liabilities | β | β | β | β | β | $0.9M |
| Current assets | $36.3M | $228M | $129M | $45.1M | $42.7M | $52.6M |
| Current liabilities | $3.6M | $6.2M | $10.5M | $8.5M | $4.4M | $5.7M |
| Inventory | $0.7M | $1.0M | $3.6M | $1.1M | $0.1M | $0.3M |
| Property and equipment, net | $1.4M | $7.1M | $7.6M | $4.8M | $4.2M | $8.9M |
| Goodwill | β | β | β | β | $0.0M | $14.7M |
| Intangible assets | β | β | $19.1M | $0.0M | β | $10.4M |
| Total assets | $38.1M | $236M | $168M | $60.4M | $56.3M | $95.7M |
| Total liabilities | $5.1M | $21.9M | $23.2M | $19.5M | $65.8M | $21.0M |
| Shareholders' equity | $32.9M | $214M | $144M | $40.9M | β$9.5M | $74.7M |
| Margins | ||||||
| Gross margin | 36.4% | 23.8% | 20.3% | 18.0% | 55.2% | 48.7% |
| Operating margin | β238.3% | β1,595.9% | β1,215.2% | β1,968.0% | β345.8% | β617.7% |
| EBITDA margin | β233.1% | β1,585.4% | β1,205.5% | β1,942.8% | β335.2% | β599.1% |
| Net margin | β237.4% | β1,606.1% | β1,078.5% | β1,880.8% | β932.7% | 191.4% |
| FCF margin | β202.3% | β922.0% | β459.1% | β1,259.4% | β294.0% | β540.4% |
| Net interest share of revenue | 0.5% | β0.7% | 12.6% | 53.6% | 16.0% | 37.1% |
| Returns | ||||||
| Return on capital employed | β60.9% | β35.3% | β112.7% | β232.7% | β52.0% | β36.0% |
| Return on equity | β63.6% | β66.0% | β87.7% | β124.7% | β462.9% | 30.8% |
| Return on assets | β55.0% | β59.5% | β77.9% | β101.4% | β124.5% | 13.2% |
| Return on tangible equity | β63.6% | β38.1% | β125.4% | β282.6% | β | 20.3% |
| Growth | ||||||
| Revenue growth | β | β42.4% | 187.1% | β57.8% | 26.7% | β32.6% |
| Share count change | β | 13.1% | β78.4% | 4.8% | 4.4% | 57.3% |
| Financial health | ||||||
| Current ratio | 10.2x | 37.1x | 12.3x | 5.3x | 9.6x | 9.3x |
| Quick ratio | 10.0x | 36.9x | 11.9x | 5.2x | 9.6x | 9.2x |
| Capital allocation | ||||||
| Capex / revenue | 10.8% | 92.4% | 10.3% | 12.7% | 3.4% | 13.6% |
| Stock comp / revenue | 26.0% | 849.6% | 244.7% | 195.9% | 36.0% | 84.8% |
| Quality scores | ||||||
| Piotroski F-score | β | 3.0 | 3.0 | 2.0 | 5.0 | 2.0 |
| Altman Z'' | 3.2 | 12.1 | β1.8 | β29.8 | β27.3 | β11.7 |
| Accruals ratio | β10.6% | β28.8% | β45.5% | β34.2% | β85.7% | 49.6% |
Source: SEC EDGAR XBRL filings (CIK 0001826681). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.